NCT03147534

Brief Summary

Compare and assess the accuracy and reliability of the InstaTemp MD® device to techniques presently in use for measuring temperature in infants and children in a Canadian clinical setting.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Feb 2017

Typical duration for not_applicable healthy

Geographic Reach
1 country

2 active sites

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2017

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 19, 2017

Completed
21 days until next milestone

First Posted

Study publicly available on registry

May 10, 2017

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 8, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 8, 2018

Completed
Last Updated

January 14, 2021

Status Verified

January 1, 2021

Enrollment Period

1.3 years

First QC Date

April 19, 2017

Last Update Submit

January 12, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Temperature measurements using "Welch Allyn" (oral/rectal), Covidien (tympanic) and ARC InstaTempMD (non-touch, infrared) in degrees Celcius and will be compared with three consecutive measurements with each thermometer.

    Compare the compendia thermometers in each age range to the InstaTemp MD to determine average clinical bias.

    Participant will only be required to attend one visit which will last up to a maximum of 30 minutes for the duration of the study.

Secondary Outcomes (1)

  • Mean Comparison Analysis. Temperature measurements using "Welch Allyn" (oral/recta.), Covidien (tympanic) and ARC InstaTemp MD (non-touch, infrared) in degrees Celcius and will be compared with three consecutive measurements with each thermometer.

    Participant will only be required to attend one visit which will last up to a maximum of 30 minutes for the duration of the study.

Study Arms (3)

Children Age 1 month to 2 years

ACTIVE COMPARATOR

Collecting temperatures on patients using the ARC InstaTemp MD and a "Welch Allyn" rectal thermometer.

Device: InstaTemp MDDevice: "Welch Allyn", rectal

Children > 2 to 5 years

ACTIVE COMPARATOR

Collecting temperatures on patients using the ARC InstaTemp MD, the "Welch Allyn" rectal and Covidien tympanic thermometer.

Device: InstaTemp MDDevice: "Welch Allyn", rectalDevice: Covidien, tympanic

Children > 5 to ≤ 10 years

ACTIVE COMPARATOR

Collecting temperatures on patients using the ARC InstaTemp MD, the "Welch Allyn" oral and the Covidien tympanic thermometer.

Device: InstaTemp MDDevice: "Welch Allyn", oralDevice: Covidien, tympanic

Interventions

The InstaTemp MD is a hand held electronic infrared thermometer that is intended to accurately measure human body temperature without contact with the human body.

Children > 2 to 5 yearsChildren > 5 to ≤ 10 yearsChildren Age 1 month to 2 years

The "Welch Allyn" rectal thermometer is intended to measure human body temperature.

Children > 2 to 5 yearsChildren Age 1 month to 2 years

The "Welch Allyn" oral thermometer is intended to measure human body temperature.

Children > 5 to ≤ 10 years

The Covidien tympanic thermometer is intended to measure human body temperature.

Children > 2 to 5 yearsChildren > 5 to ≤ 10 years

Eligibility Criteria

Age1 Month - 10 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Children Age 1 month to ≤ 10 years old
  • Male or female
  • Subject's parent or legal guardian over the age of 18 years must sign an informed consent form before any study-related procedures are performed
  • Subjects who in the opinion of the investigator (or as required by the ethics committee) have the capacity to understand and sign an assent form, must provide written assent

You may not qualify if:

  • Subjects who in the opinion of the researcher are too agitated, distressed or who are otherwise unable to cooperate with study procedures
  • Subjects whose forehead cannot be fully exposed to the ambient condidtions for at least 15 minutes.
  • Subjects with signs or recent history of inflammation or infection of the forehead or at the reference clinical test site.
  • Subjects currently using cooling blankets or fans
  • Subjects currently receiving treatment with thyroxine, barbiturates, antipsychotics, cortico-steroids (oral iv, or topically applied to forehead)
  • Subjects currently alcohol intoxicated
  • Subjects with documented illicit durg use in the previous 5 days
  • Subjects that have had any hot or cold drinks within 15 minutes prior to a sublingual reading
  • Subject is taking any medication that in the opinion of the investigator may alter the temperature of the child
  • Subjects participating in a clinical trial of an investigational medicinal product within the last 30 days.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Center for Pediatric Excellence

Ottawa, Ontario, K2G1W2, Canada

Location

Agoo Children's Health and Wellness Centre

Laval, Quebec, H7P 0H9, Canada

Location

MeSH Terms

Interventions

Administration, Rectal

Intervention Hierarchy (Ancestors)

Administration, MucosalAdministration, TopicalDrug Administration RoutesDrug TherapyTherapeutics

Study Officials

  • Judy van Stralen, MD FRCPC

    Center for Pediatric Excellence

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 19, 2017

First Posted

May 10, 2017

Study Start

February 1, 2017

Primary Completion

May 8, 2018

Study Completion

May 8, 2018

Last Updated

January 14, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

Locations